Kelly Chien, MD

home / authors / kelly-chien-md

Kelly Chien, MD, is an assistant Professor in the department of leukemia, division of cancer medicine, The University of Texas MD Anderson Cancer Center, in Houston, TX.

Articles

Addressing MDS Treatment Gap Post Hypomethylating Failure

Addressing MDS Treatment Gap Post Hypomethylating Failure

March 21st 2024

The frontline standard-of-care regimen for patients with higher-risk MDS and some with lower-risk MDS remain hypomethylating agents, such as azacitidine, decitabine, and decitabine/cedazuridine.